Spots Global Cancer Trial Database for bone scan

Every month we try and update this database with for bone scan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)	NCT05564403	Recurrent Bilia... Recurrent Dista... Recurrent Gallb... Recurrent Intra... Stage III Dista... Stage III Hilar... Stage III Intra... Stage IV Distal... Stage IV Hilar ... Stage IV Intrah... Unresectable Bi... Unresectable Di... Unresectable Ga... Unresectable In...	Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Echocardiograph... Fluorouracil Leucovorin Calc... Magnetic Resona... Multigated Acqu... Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer	NCT03085043	Prostate Carcin...	Bone Scan Computed Tomogr... Magnetic Resona... Magnetic Resona...	18 Years -	M.D. Anderson Cancer Center
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)	NCT06401330	Stage I Kidney ... Stage II Kidney... Stage III Kidne... Stage IV Kidney...	Bone Scan Carboplatin Computed Tomogr... Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Magnetic Resona... Nephrectomy Patient Observa... Positron Emissi... Ultrasound Imag... Vincristine X-Ray Imaging	- 30 Years	Children's Oncology Group
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer	NCT06129851	Stage IIC Prost... Stage III Prost... Stage IV Prosta...	Biospecimen Col... Bone Scan Brachytherapy Computed Tomogr... Dual X-ray Abso... External Beam R... Magnetic Resona... PSMA PET Scan Questionnaire A... Relugolix	18 Years -	University of Kansas Medical Center
Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer	NCT02453620	Anatomic Stage ... Anatomic Stage ... Breast Adenocar... Invasive Breast... Malignant Solid...	Biopsy Blood Sample Bone Scan Computed Tomogr... Entinostat Ipilimumab Nivolumab Pharmacogenomic... Pharmacological... Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer	NCT05733351	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Abiraterone Biospecimen Col... Bone Scan Computed Tomogr... Docetaxel Enzalutamide FDG-Positron Em... Magnetic Resona... PSMA PET Scan Vudalimab	18 Years -	Emory University
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study	NCT05092958	Advanced Bladde... Advanced Renal ... Advanced Ureter... Advanced Urethr... Metastatic Blad... Metastatic Rena... Metastatic Uret... Metastatic Uret... Stage III Bladd... Stage III Renal... Stage III Renal... Stage III Urete... Stage III Ureth... Stage IV Bladde... Stage IV Renal ... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr...	Avelumab Biospecimen Col... Bone Scan Cabozantinib S-... Computed Tomogr... Magnetic Resona... Quality-of-Life... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer	NCT00996749	Stage III Prost...	omega-3 fatty a... bone scan dual x-ray abso... laboratory biom... biopsy	18 Years -	Wake Forest University Health Sciences
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer	NCT03199885	Metastatic Brea... Metastatic HER2... Recurrent Breas... Recurrent HER2-... Stage III Breas... Stage IV Breast... Unresectable Br... Unresectable HE...	Atezolizumab Biopsy Bone Scan Computed Tomogr... Docetaxel Magnetic Resona... Paclitaxel Pertuzumab Placebo Adminis... Quality-of-Life... Trastuzumab	18 Years -	National Cancer Institute (NCI)
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial	NCT05564377	Advanced Malign... Anatomic Stage ... Anatomic Stage ... Locally Advance... Malignant Femal... Metastatic HER2... Metastatic Mali... Recurrent Endom... Recurrent Fallo... Recurrent Malig... Recurrent Malig... Recurrent Ovari... Recurrent Prima... Unresectable HE... Unresectable Ma...	Alpelisib Binimetinib Biopsy Biospecimen Col... Bone Marrow Asp... Bone Scan Computed Tomogr... Echocardiograph... Fluorouracil Fulvestrant Ipatasertib Leucovorin Magnetic Resona... Multigated Acqu... Mutation Carrie... Neratinib Malea... Nilotinib Hydro... Olaparib Oxaliplatin Paclitaxel Palbociclib Panitumumab Positron Emissi... Selumetinib Sul... Sotorasib	-	National Cancer Institute (NCI)
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer	NCT06130826	Breast Carcinom... Colorectal Carc...	Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Immunotherapy Magnetic Resona... Positron Emissi... Stereotactic Bo...	18 Years -	City of Hope Medical Center
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial	NCT05554367	Malignant Solid... Ovarian Low Gra... Pancreatic Carc... Stage IV Ovaria... Stage IV Pancre...	Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Palbociclib	18 Years -	National Cancer Institute (NCI)
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones	NCT04090398	Anatomic Stage ... Metastatic HER2... Metastatic Mali...	Biospecimen Col... Bone Scan Computed Tomogr... Electronic Heal... Magnetic Resona... Paclitaxel Radium Ra 223 D... Single Photon E...	18 Years -	National Cancer Institute (NCI)
F-18 Sodium Fluoride in Prostate Cancer	NCT01240551	Prostate Neopla...	F-18 NaF	18 Years -	National Institutes of Health Clinical Center (CC)
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer	NCT06029270	Metastatic Naso... Recurrent Nasop... Stage IV Nasoph...	Biospecimen Col... Bone Scan Carboplatin Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nivolumab Positron Emissi... Relatlimab	18 Years -	National Cancer Institute (NCI)
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma	NCT05691478	High Grade Oste... Localized Osteo... Metastatic Oste... Secondary Osteo...	Bone Scan Cabozantinib S-... Cisplatin Computed Tomogr... Doxorubicin Hyd... Magnetic Resona... Methotrexate Surgical Proced... X-Ray Imaging	- 40 Years	National Cancer Institute (NCI)
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.	NCT00414934	Cancer		18 Years -	National Taiwan University Hospital
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT06200103	Castration-Resi... Stage IVB Prost...	Biospecimen Col... Bone Scan Clinical Observ... Computed Tomogr... Gallium Ga 68 G... Lutetium Lu 177... Positron Emissi... Questionnaire A... Single Photon E...	18 Years -	Mayo Clinic
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones	NCT04090398	Anatomic Stage ... Metastatic HER2... Metastatic Mali...	Biospecimen Col... Bone Scan Computed Tomogr... Electronic Heal... Magnetic Resona... Paclitaxel Radium Ra 223 D... Single Photon E...	18 Years -	National Cancer Institute (NCI)
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer	NCT03085043	Prostate Carcin...	Bone Scan Computed Tomogr... Magnetic Resona... Magnetic Resona...	18 Years -	M.D. Anderson Cancer Center
68Ga-PSMA PET/CT for Ra223 Assessment	NCT04951817	Metastatic Pros...	Ga-68 PSMA liga...	40 Years - 85 Years	Chang Gung Memorial Hospital
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer	NCT06029270	Metastatic Naso... Recurrent Nasop... Stage IV Nasoph...	Biospecimen Col... Bone Scan Carboplatin Cisplatin Computed Tomogr... Gemcitabine Magnetic Resona... Nivolumab Positron Emissi... Relatlimab	18 Years -	National Cancer Institute (NCI)
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer	NCT02849496	Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic Brea... Metastatic HER2... Unresectable Br... Unresectable HE...	Atezolizumab Biopsy Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Bone Scan Computed Tomogr... Magnetic Resona... Olaparib Positron Emissi... Questionnaire A... X-Ray Imaging	18 Years -	National Cancer Institute (NCI)
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer	NCT06094842	Prostate Carcin... Prostate Small ... Stage III Prost... Stage IV Prosta...	Bendamustine Biopsy Biospecimen Col... Bone Scan Bridge Therapy Computed Tomogr... Cyclophosphamid... Echocardiograph... Fludarabine Leukapheresis Multigated Acqu... T-cell Receptor... X-Ray Imaging	18 Years -	Fred Hutchinson Cancer Center
Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)	NCT05554354	Anatomic Stage ... Metastatic HER2... Metastatic Horm...	Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Echocardiograph... Fulvestrant Magnetic Resona... Multigated Acqu...	18 Years -	National Cancer Institute (NCI)
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases	NCT00375830	Cancer	Bone scan 99mTc-methyl di... Positron Emissi... 18F-Fludeoxyglu... Computed Tomogr... 18F-Sodium Fluo... Whole Body Magn... Gadopentetate d... Gadofosveset Gadobutrol	18 Years -	Stanford University
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer	NCT05676463	Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros...	MRI-guided Inte... Antiandrogen Th... PSMA PET Scan Computed Tomogr... Magnetic Resona... Bone Scan Biospecimen Col... Quality-of-Life...	18 Years -	Thomas Jefferson University
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases	NCT00375830	Cancer	Bone scan 99mTc-methyl di... Positron Emissi... 18F-Fludeoxyglu... Computed Tomogr... 18F-Sodium Fluo... Whole Body Magn... Gadopentetate d... Gadofosveset Gadobutrol	18 Years -	Stanford University
FOcal RECurrent Assessment and Salvage Treatment	NCT01883128	Progression of ...	Whole Body MRI Focal Salvage T... MRI Targeted bi...	18 Years -	University College London Hospitals
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial	NCT05554367	Malignant Solid... Ovarian Low Gra... Pancreatic Carc... Stage IV Ovaria... Stage IV Pancre...	Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Palbociclib	18 Years -	National Cancer Institute (NCI)
18F-fluorocholine and 18F-fluoride PET in Prostate Cancer	NCT04340765	Prostate Cancer Fluorocholine	18F-fluorocholi...	20 Years -	Buddhist Tzu Chi General Hospital
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)	NCT05564403	Recurrent Bilia... Recurrent Dista... Recurrent Gallb... Recurrent Intra... Stage III Dista... Stage III Hilar... Stage III Intra... Stage IV Distal... Stage IV Hilar ... Stage IV Intrah... Unresectable Bi... Unresectable Di... Unresectable Ga... Unresectable In...	Binimetinib Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Echocardiograph... Fluorouracil Leucovorin Calc... Magnetic Resona... Multigated Acqu... Oxaliplatin	18 Years -	National Cancer Institute (NCI)
Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma	NCT06049576	Clear Cell Rena... Sarcomatoid Ren... Stage III Renal... Stage IV Renal ...	Biospecimen Col... Bone Scan Computed Tomogr... Ipilimumab Magnetic Resona... Myrciaria dubia... Nivolumab	18 Years -	City of Hope Medical Center
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer	NCT06305598	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Biopsy Bone Scan Computed Tomogr... Leuprolide Acet... Magnetic Resona... Survey Administ... Testosterone Cy...	18 Years -	Roswell Park Cancer Institute
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer	NCT00996749	Stage III Prost...	omega-3 fatty a... bone scan dual x-ray abso... laboratory biom... biopsy	18 Years -	Wake Forest University Health Sciences
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed	NCT02761057	Locally Advance... Metastatic Papi... Stage III Renal... Stage IV Renal ... Type 1 Papillar... Type 2 Papillar... Unresectable Re...	Biospecimen Col... Bone Scan Cabozantinib S-... Computed Tomogr... Crizotinib Savolitinib Sunitinib Malat...	18 Years -	National Cancer Institute (NCI)
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer	NCT01967862	Recurrent Prost...	computed tomogr... bone scan 3-Tesla magneti... diffusion-weigh... fluorine F 18 s... computed tomogr... positron emissi... laboratory biom...	18 Years -	City of Hope Medical Center
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy	NCT04071236	Castration-Resi... Metastatic Mali... Metastatic Pros... Stage IV Prosta...	Avelumab Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Peposertib Questionnaire A... Radium Ra 223 D...	18 Years -	National Cancer Institute (NCI)
F-18 Sodium Fluoride in Prostate Cancer	NCT01240551	Prostate Neopla...	F-18 NaF	18 Years -	National Institutes of Health Clinical Center (CC)
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers	NCT04432597	HPV Positive Ca... Vulvar, Vaginal... Anal Cancer Oropharyngeal C... Cervical Cancer	PRGN-2009 (Phas... PRGN-2009 (Phas... M7824 MRI Bone scan CT scan Brain CT Brain MRI Biopsy (Phase I... Biopsy (Phase I...	18 Years -	National Institutes of Health Clinical Center (CC)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy	NCT03959085	B Acute Lymphob... B Lymphoblastic... Central Nervous... Mixed Phenotype... Testicular Leuk...	Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Bone Scan Calaspargase Pe... Computed Tomogr... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Leucovorin Calc... Magnetic Resona... Mercaptopurine Methotrexate Pegaspargase Positron Emissi... Prednisolone Questionnaire A... Radiation Thera... Radiation Thera... Thioguanine Vincristine Sul...	1 Year - 25 Years	Children's Oncology Group
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes	NCT03375307	Advanced Bladde... Advanced Genito... Metastatic Blad... Metastatic Geni... Stage III Bladd... Stage IV Bladde...	Biopsy Biospecimen Col... Bone Marrow Bio... Bone Scan Computed Tomogr... Magnetic Resona... Olaparib Positron Emissi...	18 Years -	National Cancer Institute (NCI)
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer	NCT01967862	Recurrent Prost...	computed tomogr... bone scan 3-Tesla magneti... diffusion-weigh... fluorine F 18 s... computed tomogr... positron emissi... laboratory biom...	18 Years -	City of Hope Medical Center
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study	NCT03266744	Metastatic Brea...	Computerised To... Whole Body Magn... Bone scan	18 Years -	East and North Hertfordshire NHS Trust
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer	NCT05676463	Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros...	MRI-guided Inte... Antiandrogen Th... PSMA PET Scan Computed Tomogr... Magnetic Resona... Bone Scan Biospecimen Col... Quality-of-Life...	18 Years -	Thomas Jefferson University
Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer	NCT04936230	Metastatic Urot... Platinum-Resist... Stage IV Bladde...	Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Pembrolizumab Positron Emissi... Questionnaire A... Stereotactic Bo...	18 Years -	National Cancer Institute (NCI)
Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial	NCT06378866	Recurrent Castr... Stage IVB Prost... Recurrent Prost... Castration-resi...	Abiraterone Apalutamide Biospecimen Col... Bone Scan Computed Tomogr... Darolutamide Degarelix Enzalutamide Goserelin Histrelin Leuprolide Magnetic Resona... Patient Observa... Positron Emissi... Prednisone Questionnaire A... Relugolix Stereotactic Bo... Triptorelin	18 Years -	Mayo Clinic
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)	NCT06401330	Stage I Kidney ... Stage II Kidney... Stage III Kidne... Stage IV Kidney...	Bone Scan Carboplatin Computed Tomogr... Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Magnetic Resona... Nephrectomy Patient Observa... Positron Emissi... Ultrasound Imag... Vincristine X-Ray Imaging	- 30 Years	Children's Oncology Group
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.	NCT00414934	Cancer		18 Years -	National Taiwan University Hospital
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer	NCT05438563	Prostate Carcin... Stage I Prostat... Stage II Prosta...	MRI-Guided Tran... Quality-of-Life... Questionnaire A... Digital Rectal ... Cystoscopy Biopsy Bone Scan PSMA PET Scan Multiparametric...	45 Years - 80 Years	Mayo Clinic
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer	NCT06130826	Breast Carcinom... Colorectal Carc...	Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Immunotherapy Magnetic Resona... Positron Emissi... Stereotactic Bo...	18 Years -	City of Hope Medical Center
Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working	NCT05432791	Locally Advance... Metastatic Uter... Stage III Uteri... Stage IV Uterin... Unresectable Ut...	Biospecimen Col... Bone Scan Computed Tomogr... Magnetic Resona... Multigated Acqu... Olaparib Pazopanib Temozolomide Trabectedin Transthoracic E...	18 Years -	National Cancer Institute (NCI)
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer	NCT04777071	Biochemically R... Castration-Resi... Prostate Adenoc... Stage IV Prosta...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi... Magnetic Resona... Bone Scan	18 Years -	University of Washington
Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer	NCT04579224	Metastatic Blad... Metastatic Rena... Metastatic Uret... Metastatic Uret... Metastatic Urot... Refractory Blad... Refractory Rena... Refractory Uret... Refractory Uret... Refractory Urot... Stage IV Bladde... Stage IV Renal ... Stage IV Renal ... Stage IV Ureter... Stage IV Urethr... Stage IVA Bladd... Stage IVB Bladd...	Biospecimen Col... Bone Scan Computed Tomogr... Docetaxel Eribulin Mesyla... Gemcitabine Hyd... Magnetic Resona... Paclitaxel Sacituzumab Gov...	18 Years -	National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)	NCT03155620	Advanced Malign... Ann Arbor Stage... Ann Arbor Stage... Histiocytic Sar... Juvenile Xantho... Langerhans Cell... Malignant Gliom... Recurrent Child... Recurrent Epend... Recurrent Ewing... Recurrent Gliom... Recurrent Hepat... Recurrent Lange... Recurrent Malig... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Non-H... Recurrent Osteo... Recurrent Perip... Recurrent Prima... Recurrent Rhabd... Recurrent Soft ... Refractory Ewin... Refractory Glio... Refractory Hepa... Refractory Lang... Refractory Mali... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Non-... Refractory Oste... Refractory Peri... Refractory Prim... Refractory Rhab... Refractory Rhab... Rhabdoid Tumor Stage III Osteo... Stage III Soft ... Stage IV Osteos... Stage IV Soft T... Stage IVA Osteo... Stage IVB Osteo... Wilms Tumor	Biopsy Biospecimen Col... Bone Marrow Asp... Bone Scan Computed Tomogr... Ensartinib Erdafitinib Laboratory Biom... Larotrectinib S... Magnetic Resona... Mutation Carrie... Olaparib Palbociclib Pharmacological... Positron Emissi... Radionuclide Im... Samotolisib Selpercatinib Selumetinib Sul... Tazemetostat Tipifarnib Ulixertinib Vemurafenib X-Ray Imaging	12 Months - 21 Years	National Cancer Institute (NCI)
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial	NCT06244004	Castration-Sens... Metastatic Pros... Stage IVB Prost...	Antiandrogen Th... Bone Scan Computed Tomogr... Cytotoxic Chemo... FDG-Positron Em... Radiation Thera...	18 Years -	Northwestern University
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study	NCT03266744	Metastatic Brea...	Computerised To... Whole Body Magn... Bone scan	18 Years -	East and North Hertfordshire NHS Trust
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	NCT03866382	Bladder Adenoca... Bladder Clear C... Bladder Mixed A... Bladder Neuroen... Bladder Small C... Bladder Squamou... Chromophobe Ren... Collecting Duct... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Kidney Medullar... Large Cell Neur... Malignant Testi... Malignant Testi... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Chro... Metastatic Kidn... Metastatic Mali... Metastatic Papi... Metastatic Peni... Metastatic Pros... Metastatic Sarc... Metastatic Uret... Papillary Renal... Sarcomatoid Ren... Stage IV Bladde... Stage IV Penile... Stage IV Renal ... Stage IV Urethr... Stage IVB Prost... Urachal Adenoca... Urethral Clear ...	Bone Scan Cabozantinib S-... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer	NCT04981509	Hereditary Leio... Papillary Renal... Renal Cell Carc... Sporadic Papill... Stage III Renal... Stage IV Renal ...	Atezolizumab Bevacizumab Biopsy Biospecimen Col... Bone Scan Computed Tomogr... Computed Tomogr... Erlotinib Magnetic Resona... Positron Emissi... Sodium Fluoride...	12 Years -	National Cancer Institute (NCI)
Supraphysiological Androgen to Enhance Chemotherapy Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study	NCT06039371	Castration-Resi... Metastatic Pros... Stage IVB Prost...	Biopsy Biospecimen Col... Bone Scan Carboplatin Computed Tomogr... Etoposide Quality-of-Life... Questionnaire A... Testosterone Cy...	18 Years -	University of Washington

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world:

Spots Global Cancer Trial Database for bone scan

Every month we try and update this database with for bone scan cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for bone scan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.